Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia

Vesa Lindström, Janne Aittoniemi, Urpu Salmenniemi, Helena Käyhty, Heini Huhtala, Maija Itälä-Remes, Marjatta Sinisalo

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Originalspråkengelska
TidskriftHuman Vaccines & Immunotherapeutics
Volym14
Utgåva6
Sidor (från-till)1471-1474
Antal sidor4
ISSN2164-5515
DOI
StatusPublicerad - 2018
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3122 Cancersjukdomar

Citera det här

Lindström, Vesa ; Aittoniemi, Janne ; Salmenniemi, Urpu ; Käyhty, Helena ; Huhtala, Heini ; Itälä-Remes, Maija ; Sinisalo, Marjatta. / Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia. I: Human Vaccines & Immunotherapeutics. 2018 ; Vol. 14, Nr. 6. s. 1471-1474.
@article{e2eb43291db44190b86244588811fad0,
title = "Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia",
keywords = "antibody persistence, chronic lymphocytic leukemia, pneumococcal conjugate vaccine, IMMUNOGENICITY, PATHOGENESIS, RESPONSES, VACCINES, SAFETY, TRIAL, 3122 Cancers",
author = "Vesa Lindstr{\"o}m and Janne Aittoniemi and Urpu Salmenniemi and Helena K{\"a}yhty and Heini Huhtala and Maija It{\"a}l{\"a}-Remes and Marjatta Sinisalo",
year = "2018",
doi = "10.1080/21645515.2018.1436424",
language = "English",
volume = "14",
pages = "1471--1474",
journal = "Human Vaccines & Immunotherapeutics",
issn = "2164-5515",
publisher = "TAYLOR & FRANCIS INC",
number = "6",

}

Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia. / Lindström, Vesa; Aittoniemi, Janne; Salmenniemi, Urpu; Käyhty, Helena; Huhtala, Heini; Itälä-Remes, Maija; Sinisalo, Marjatta.

I: Human Vaccines & Immunotherapeutics, Vol. 14, Nr. 6, 2018, s. 1471-1474.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

TY - JOUR

T1 - Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia

AU - Lindström, Vesa

AU - Aittoniemi, Janne

AU - Salmenniemi, Urpu

AU - Käyhty, Helena

AU - Huhtala, Heini

AU - Itälä-Remes, Maija

AU - Sinisalo, Marjatta

PY - 2018

Y1 - 2018

KW - antibody persistence

KW - chronic lymphocytic leukemia

KW - pneumococcal conjugate vaccine

KW - IMMUNOGENICITY

KW - PATHOGENESIS

KW - RESPONSES

KW - VACCINES

KW - SAFETY

KW - TRIAL

KW - 3122 Cancers

U2 - 10.1080/21645515.2018.1436424

DO - 10.1080/21645515.2018.1436424

M3 - Article

VL - 14

SP - 1471

EP - 1474

JO - Human Vaccines & Immunotherapeutics

JF - Human Vaccines & Immunotherapeutics

SN - 2164-5515

IS - 6

ER -